SCHEMBL985103

SCHEMBL985103

Cc1cc(C)c2c(c1)C(=O)c1ccccc1C2=O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TTR P02766 2/20 0.62
ELANE P08246 3/20 0.59
KMT2A Q03164 4/20 0.50
ALDH1A1 P00352 4/20 0.50
CYP3A4 P08684 3/20 0.50
TSHR P16473 3/20 0.50
MEN1 O00255 3/20 0.50
MAPK1 P28482 3/20 0.50
RAB9A P51151 3/20 0.50
L3MBTL1 Q9Y468 3/20 0.50
MAPT P10636 3/20 0.50
TDP1 Q9NUW8 3/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
NPC1 O15118 1/20 0.50
CASP3 P42574 1/20 0.50
HBB P68871 1/20 0.50
SENP7 Q9BQF6 1/20 0.50
SENP6 Q9GZR1 1/20 0.50
KDM4E B2RXH2 1/20 0.50
USP2 O75604 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8668950 0.92 ELANE (0.53) TTRELANEKMT2AALDH1A1CYP3A4
SCHEMBL12460172 0.92 ELANE (0.59) TTRELANEKMT2AALDH1A1CYP3A4
SCHEMBL6904482 0.87 ELANE (0.45) TTRELANEKMT2AALDH1A1CYP3A4
SCHEMBL6905738 0.86 ELANE (0.62) TTRELANEKMT2AALDH1A1CYP3A4
SCHEMBL31379951 0.86 ELANE (0.62) TTRELANEKMT2AALDH1A1CYP3A4
SCHEMBL31484750 0.85 TTR (0.47) TTRELANEKMT2AALDH1A1CYP3A4
SCHEMBL6900343 0.85 ELANE (0.53) TTRELANEKMT2AALDH1A1CYP3A4
SCHEMBL8771223 0.84 ELANE (0.53) TTRELANEKMT2AALDH1A1CYP3A4
SCHEMBL27563138 0.83 ELANE (0.44) TTRELANEKMT2AALDH1A1CYP3A4
SCHEMBL12111227 0.83 ELANE (0.50) TTRELANEKMT2AALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118198566-A Repairing and regenerating method of waste positive electrode material and regenerated positive electrode material 厦门厦钨新能源材料股份有限公司 2024-06-14 CN claimed
CN-111867970-B Method for producing aqueous hydrogen peroxide solution 索尔维公司 2023-08-25 CN claimed
EP-3768636-B1 PROCESS FOR MANUFACTURING AN AQUEOUS HYDROGEN PEROXIDE SOLUTION SOLVAY (BE) 2023-06-14 EP claimed
CN-105106981-B Dianthranide quinones application in preparation of anti-tumor drugs 江苏省中医药研究院 2018-12-28 CN claimed
CN-108455536-A Peroxidating method for preparing hydrogen 三菱瓦斯化学株式会社 2018-08-28 CN claimed
CN-105473509-B Process for reducing total organic carbon in wastewater 巴斯夫欧洲公司 2018-05-18 CN claimed
US-5662878-A HYDROGENATION OF ANTHRAQUINONE SOLUTION, MIXING OXYGEN FOR OXIDATION AND FORMING PEROXIDE UNIVERSITY OF CHICAGO (US) 1997-09-02 US claimed
CN-117105178-A Method for producing hydrogen peroxide 三菱瓦斯化学株式会社 2023-11-24 CN disclosed
CN-109467057-B Process for producing working solution for use in producing hydrogen peroxide 三菱瓦斯化学株式会社 2023-05-05 CN disclosed
US-10451967-B2 Acid- and radical-generating agent and method for generating acid and radical FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) 2019-10-22 US disclosed
CN-208471534-U The manufacture system of hydrogen peroxide 三菱瓦斯化学株式会社 2019-02-05 CN disclosed
CN-105106981-B Dianthranide quinones application in preparation of anti-tumor drugs 江苏省中医药研究院 2018-12-28 CN disclosed
CN-208265777-U The manufacture system of hydrogen peroxide 三菱瓦斯化学株式会社 2018-12-21 CN disclosed
US-6815481-B2 FUSED DIBENZO THERMAL STABILIZERS SUCH AS ANTHRACENE, XANTHENE AND ANTHRONE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-11-09 US disclosed
CN-1362464-A Organic electroluminescent material UNIV QINGHUA (CN) 2002-08-07 CN disclosed
US-20020032256-A1 Polybutadiene composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2002-03-14 US disclosed
US-6180804-B1 TETRAHYDRO ALKYLANTHRAQUINONEEPOXIDE WITH BOEHMITE FMC CORPORATION 2001-01-30 US disclosed
US-5662878-A HYDROGENATION OF ANTHRAQUINONE SOLUTION, MIXING OXYGEN FOR OXIDATION AND FORMING PEROXIDE UNIVERSITY OF CHICAGO (US) 1997-09-02 US disclosed
US-4374820-A Manufacture of H2 O2 E. I. DU PONT DE NEMOURS AND COMPANY (US) 1983-02-22 US disclosed
US-4355012-A Mixed anthraquinonedisulfonic acids AMERICAN COLOR & CHEMICAL CORPORATION (US) 1982-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10451967-B2 Acid- and radical-generating agent and method for generating acid and radical CBR1, HAO2, CBR3 TTR 3745/4885ELANE 1630/4885KMT2A 3389/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.